Proton pump inhibitor (ppi)    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
298Hereditary pancreatitis1

298. Hereditary pancreatitis    [ 93 clinical trials,   168 drugs,   (DrugBank: 51 drugs),   48 drug target genes,   134 drug target pathways]
Searched query = "Hereditary pancreatitis", "Chronic pancreatitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 93 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00559364
(ClinicalTrials.gov)
November 200714/11/2007Safety and Efficacy Study of ViokaseĀ® 16 for the Correction of SteatorrheaA Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled, Phase III Study to Assess the Safety and Efficacy of ViokaseĀ® 16 for the Correction of Steatorrhea in Patients With Exocrine Pancreatic InsufficiencyExocrine Pancreatic Insufficiency;Chronic Pancreatitis;PancreatectomyDrug: ViokaseĀ® 16;Drug: Placebo;Drug: Proton pump inhibitor (PPI);Drug: OmeprazoleForest LaboratoriesNULLCompleted18 Years80 YearsAll50Phase 3United States;Canada;Poland;Slovakia;Germany